These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25556715)

  • 1. Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.
    Heil EL; Lowery AV; Thom KA; Nicolau DP
    Pharmacotherapy; 2015 Jan; 35(1):54-8. PubMed ID: 25556715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
    Yamada T; Ishiguro N; Oku K; Higuchi I; Nakagawa I; Noguchi A; Yasuda S; Fukumoto T; Iwasaki S; Akizawa K; Furugen A; Yamaguchi H; Iseki K
    Biol Pharm Bull; 2015; 38(9):1430-3. PubMed ID: 26155936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
    Sun HY; Shields RK; Cacciarelli TV; Muder RR; Singh N
    Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
    Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
    Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
    Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
    Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL; Parada JP; Belmares J; O'Keefe JP
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents.
    Goff DA; Nicolau DP
    Clin Ther; 2013 Jun; 35(6):766-71. PubMed ID: 23795574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Vickery SB; McClain D; Wargo KA
    Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
    Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver abscess caused by multidrug-resistant Pseudomonas aeruginosa treated with colistin; a case report and review of the literature.
    Yaita K; Sameshima I; Takeyama H; Matsuyama S; Nagahara C; Hashiguchi R; Moronaga Y; Tottori N; Komatsu M; Oshiro Y; Yamaguchi Y
    Intern Med; 2013; 52(12):1407-12. PubMed ID: 23774557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
    Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
    Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician.
    Martis N; Leroy S; Blanc V
    J Infect; 2014 Jul; 69(1):1-12. PubMed ID: 24631777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
    Hernández-Tejedor A; Merino-Vega CD; Martín-Vivas A; Ruiz de Luna-González R; Delgado-Iribarren A; Gabán-Díez Á; Temprano-Gómez I; de la Calle-Pedrosa N; González-Jiménez AI; Algora-Weber A
    Infection; 2017 Feb; 45(1):115-117. PubMed ID: 27670678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
    Obritsch MD; Fish DN; MacLaren R; Jung R
    Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO
    Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.